Table of Content
1. Global Vascular Grafts Market – Executive Summary
1.1. Global Market Overview
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Fact.MR Analysis and Recommendations
2. Global Vascular Grafts Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Introduction and Definition
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Vascular Grafts
3.1.2. COVID-19 Crisis and Impact on Aprotic Solvent Prices
3.1.3. COVID-19 Impact Benchmark with Previous Crisis
3.1.3.1. Change in Vascular Grafts Demand
3.1.3.2. Before and After COVID-19 Crisis (Projected)
3.1.3.3. Before and After Sub-prime Crisis – 2008 (Actual)
3.1.3.4. Change in Demand post Recovery Period (After Each Crisis)
3.1.4. Impact on Market and Value (US$ Mn)
3.1.4.1. Likely Loss of Value in 2020
3.1.4.2. Mid-term and Long Term Forecast
3.1.4.3. Quarter by Quarter Demand and Recovery Assessment
3.1.5. Anticipated Demand and Value Recovery Curve
3.1.5.1. Likelihood of U-Shape Recovery
3.1.5.2. Likelihood of L-Shape Recovery
3.1.6. Recovery Period Assessment by Key Countries
3.1.7. Recovery Assessment by Key Market Segments
3.1.8. Action Points and Recommendations for Suppliers
3.1.9. Impact on Trade Balance
3.2. Key Trends Impacting the Market
3.3. Formulation and Source Development Trends
4. Market Background and foundation Data Points
4.1. Need of the Hour for Industries
4.2. Industry Wise Industry 4.0
4.3. Vascular Grafts – Strategic Priorities
4.4. Life Cycle Stage
4.5. Importance of Technology
4.6. Use Cases of Vascular Grafts
4.7. Forecast Factors: Relevance and Impact
4.8. Investment Feasibility Matrix
4.9. PESTLE Analysis
4.10. Porter’s Five Forces Analysis
4.11. Market Dynamics
4.11.1. Drivers
4.11.2. Restraints
4.11.3. Opportunity Analysis
4.11.4. Trend
5. Global Vascular Grafts Market Demand (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2026
5.1. Historical Market Value (US$ Mn) Analysis, 2017-2021
5.2. Current and Future Market Value (US$ Mn) Projections, 2022-2026
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Global Vascular Grafts Market Analysis 2017-2021 and Forecast 2022-2026, By Treatment
6.1. Introduction / Key Findings
6.2. Historical Market Value (US$ Mn) Analysis By Treatment, 2017-2021
6.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Treatment, 2022-2026
6.3.1. Endovascular Aneurysm Repair (EVAR)
6.3.2. Peripheral Vascular Repair
6.3.3. Hemodialysis Access
6.4. Market Attractiveness Analysis By Treatment
7. Global Vascular Grafts Market Analysis 2017-2021 and Forecast 2022-2026, by Raw Material
7.1. Introduction / Key Findings
7.2. Historical Market Value (US$ Mn) Analysis By Raw Material , 2017-2021
7.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Raw Material, 2022-2026
7.3.1. Polyester
7.3.2. ePTFE
7.3.3. Polyurethane
7.3.4. Biosynthetic
7.4. Market Attractiveness Analysis By Raw Material
8. Global Vascular Grafts Market Analysis 2017-2021 and Forecast 2022-2026, by End User
8.1. Introduction / Key Findings
8.2. Historical Market Value (US$ Mn) Analysis By End User, 2017-2021
8.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By End User, 2022-2026
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.4. Market Attractiveness Analysis By End User
9. Global Vascular Grafts Market Analysis 2017-2021 and Forecast 2022-2026, by Region
9.1. Introduction / Key Findings
9.2. Historical Market Value (US$ Mn) Analysis By Region, 2017-2021
9.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2026
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. East Asia
9.3.5. South Asia & Oceania
9.3.6. Middle East and Africa (MEA)
9.4. Market Attractiveness Analysis By Region
10. North America Vascular Grafts Market Analysis 2017-2021 and Forecast 2022-2026
10.1. Introduction / Key Findings
10.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2022-2026
10.3.1. By Country
10.3.1.1. U.S.
10.3.1.2. Canada
10.3.2. By Treatment
10.3.3. By Raw Material
10.4. Market Attractiveness Analysis
10.4.1. By Country
10.4.2. By Treatment
10.4.3. By Raw Material
11. Latin America Vascular Grafts Market Analysis 2017-2021 and Forecast 2022-2026
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2026
11.3.1. By Country
11.3.1.1. Brazil
11.3.1.2. Mexico
11.3.1.3. Rest of Latin America
11.3.2. By Treatment
11.3.3. By Raw Material
11.3.4. By End User
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Treatment
11.4.3. By Raw Material
11.4.4. By End User
12. Europe Vascular Grafts Market Analysis 2017-2021 and Forecast 2022-2026
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2026
12.3.1. By Country
12.3.1.1. Germany
12.3.1.2. France
12.3.1.3. Italy
12.3.1.4. Spain
12.3.1.5. UK
12.3.1.6. BENELUX
12.3.1.7. Russia
12.3.1.8. Rest of Europe
12.3.2. By Treatment
12.3.3. By Raw Material
12.3.4. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Treatment
12.4.3. By Raw Material
12.4.4. By End User
13. East Asia Vascular Grafts Market Analysis 2017-2021 and Forecast 2022-2026
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2026
13.3.1. By Country
13.3.1.1. China
13.3.1.2. Japan
13.3.1.3. South Korea
13.3.2. By Treatment
13.3.3. By Raw Material
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Treatment
13.4.3. By Raw Material
13.4.4. By End User
14. South Asia & Oceania Vascular Grafts Market Analysis 2017-2021 and Forecast 2022-2026
14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2026
14.3.1. By Country
14.3.1.1. India
14.3.1.2. Thailand
14.3.1.3. Malaysia
14.3.1.4. Singapore
14.3.1.5. Vietnam
14.3.1.6. ANZ
14.3.1.7. Rest of South Asia & Oceania
14.3.2. By Treatment
14.3.3. By Raw Material
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Treatment
14.4.3. By Raw Material
14.4.4. By End User
15. Middle East and Africa Vascular Grafts Market Analysis 2017-2021 and Forecast 2022-2026
15.1. Introduction / Key Findings
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2026
15.3.1. By Country
15.3.1.1. GCC Countries
15.3.1.2. South Africa
15.3.1.3. Israel
15.3.1.4. Rest of Middle East and Africa (MEA)
15.3.2. By Treatment
15.3.3. By Raw Material
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Treatment
15.4.3. By Raw Material
15.4.4. By End User
16. Market Structure Analysis
16.1. Market Analysis by Tier of Companies
16.2. Market Concentration
16.3. Market Share Analysis of Top Players
16.4. Market Presence Analysis
17. Competition Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Competition Deep Dive
17.3.1. Endologix Inc.
17.3.1.1. Company Overview
17.3.1.2. Source overview
17.3.1.3. SWOT Analysis
17.3.1.4. Key Developments
17.3.2. OrbusNeich
17.3.2.1. Company Overview
17.3.2.2. Source overview
17.3.2.3. SWOT Analysis
17.3.2.4. Key Developments
17.3.3. Cook Medical
17.3.3.1. Company Overview
17.3.3.2. Source overview
17.3.3.3. SWOT Analysis
17.3.3.4. Key Developments
17.3.4. Cryolife
17.3.4.1. Company Overview
17.3.4.2. Source overview
17.3.4.3. SWOT Analysis
17.3.4.4. Key Developments
17.3.5. Getinge Group
17.3.5.1. Company Overview
17.3.5.2. Source overview
17.3.5.3. SWOT Analysis
17.3.5.4. Key Developments
17.3.6. LeMaitre Vascular Inc
17.3.6.1. Company Overview
17.3.6.2. Source overview
17.3.6.3. SWOT Analysis
17.3.6.4. Key Developments
17.3.7. Medtronic PLC
17.3.7.1. Company Overview
17.3.7.2. Source overview
17.3.7.3. SWOT Analysis
17.3.7.4. Key Developments
17.3.8. Terumo Medical Corporation
17.3.8.1. Company Overview
17.3.8.2. Source overview
17.3.8.3. SWOT Analysis
17.3.8.4. Key Developments
17.3.9. W.L. Gore & Associates Inc.
17.3.9.1. Company Overview
17.3.9.2. Source overview
17.3.9.3. SWOT Analysis
17.3.9.4. Key Developments
17.3.10. Vascular Graft Solution Ltd.
17.3.10.1. Company Overview
17.3.10.2. Source overview
17.3.10.3. SWOT Analysis
17.3.10.4. Key Developments
18. Assumptions And Acronyms Used
19. Research Methodology